COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1092: Articles 10911-10920  | Next

Inexpensive and colorimetric RNA detection by E. coli cell-free protein synthesis platform at room temperature
Notarangelo, M., Quattrone, A., Pizzato, M., Mansy, S. S., Toparlak, O. D.
10.1101/2021.11.29.21267025 — Posted: 2021-12-02
Genomic and phenotypic characterization of Multisystem Inflammatory Syndrome in Children (MIS-C): a prospective multicenter study from the Middle East
Abuhammour, W., Yavus, L., Jain, R., Abu Hammour, K., Al-Hammouri, G. F., EL Naofal, M., Halabi, N., Yaslam, S., Ramaswamy, S., Taylor, A., Wafadari, D., Alsarhan, A. A., Khansaheb, H., Deesi, Z., Varghese, R., Uddin, M., Alsuwaidi, H., Alkhaja, A., AlDabal, L., Loney, T., Nowotny, N., Al Khayat, A., Alsheikh-Ali, A., Abou Tayoun, A.
10.1101/2021.11.30.21267109 — Posted: 2021-12-02
Racial and ethnic disparities in maternal mental health during COVID-19
Iyengar, A. S., Ein-Dor, T., Zhang, E. X., Chan, S. J., Kaimal, A. J., Dekel, S.
10.1101/2021.11.30.21265428 — Posted: 2021-12-02
COVID-19 infection dynamics revealed by SARS-CoV-2 wastewater sequencing analysis and deconvolution
Schumann, V.-F., Cuadrat, R., Wyler, E., Wurmus, R., Deter, A., Quedenau, C., Dohmen, J., Faxel, M., Borodina, T., Altmueller, J., Gnirss, R., Boeckelmann, U., Zietzschmann, F., Uyar, B., Blume, A., Franke, V., Rajewsky, N., Landthaler, M., Akalin, A.
10.1101/2021.11.30.21266952 — Posted: 2021-12-02
Convalescent plasma for outpatients with early COVID-19
Millat-Martinez, P., Gharbharan, A., Alemany, A., Rokx, C., GeurtsvanKessel, C., Papageourgiou, G., van Geloven, N., Jordans, C., Groeneveld, G., Swaneveld, F., van der Schoot, E., Corbacho-Monne, M., Ouchi, D., Ferreira, F. P., Malchair, P., Videla, S., Garcia, V. G., Ruiz-Comellas, A., Ramirez-Morros, A., Codina, J. R., Simon, R. A., Grifols, J.-R., Blanco, J., Blanco, I., Ara, J., Bassat, Q., Clotet, B., Baro, B., Troxel, A., Zwaginga, J. J., Mitja, O., Rijnders, B.
10.1101/2021.11.30.21266810 — Posted: 2021-12-02
SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera
Sahay, R., Patil, D. Y., Sapkal, G. N., Deshpande, G. R., Shete, A. M., Nyayanit, D., Kumar, S., Dutta, S., Yadav, P. D.
10.1101/2021.11.30.470521 — Posted: 2021-12-02
Direct lysis RT-qPCR of SARS-CoV-2 in cell culture supernatant allows for fast and accurate quantification of virus, opening a vast array of applications
Craig, N., Fletcher, S. L., Daniels, A., Newman, C., O'Shea, M., Warr, A., Tait-Burkard, C.
10.1101/2021.11.30.470550 — Posted: 2021-12-02
Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination
Ng, K., Faulkner, N., Finsterbusch, K., Wu, M., Harvey, R., Hussain, S., Greco, M., Liu, Y., Kjaer, S., Swanton, C., Gandhi, S., Beale, R., Gamblin, S., Cherepanov, P., Mccauley, J., Daniels, R., Howell, M., Arase, H., Wack, A., Bauer, D., Kassiotis, G.
10.1101/2021.11.30.470568 — Posted: 2021-12-01
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
Valerio, M. F., Borges-Araujo, L., Melo, M. N., Lousa, D., Soares, C.
10.1101/2021.11.30.470470 — Posted: 2021-12-01
Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19.
McCreary, E. K., Bariola, J. R., Wadas, R. J., Shovel, J. A., Wisniewski, M. K., Adam, M., Albin, D., Minnier, T. E., Schmidhofer, M., Meyers, R., Marroquin, O. C., Collins, K., Garrard, W., Berrry, L. R., Berry, S., Crawford, A. M., McGlothlin, A., Linstrum, K., Nakayama, A., Montgomery, S. K., Snyder, G. M., Yealy, D. M., Angus, D. C., Kip, P. L., Seymour, C. W., Huang, D. T., Kip, K. E.
10.1101/2021.11.30.21266756 — Posted: 2021-12-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).